Trial intelligence / Profile preview

Long-term Plavix therapy post-stenting

NCT02327741Completed

Sponsor
Shiraz University of Medical Sciences
Start
Oct 2012
Primary completion
Sep 2014
Modality
Small Molecules
01

Overview

Open-label trial of clopidogrel in coronary artery disease (CAD), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Number of Patients With Major Bleeding Need Transfusion at 12 months. Started Oct 2012; status: completed.

02

Drugs

clopidogrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02327741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02327741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call